Expedition Medicines
Latest round
- Series B
Last raised
- Oct 2025
Total raised
- $50M
Investors
- 1
About Expedition Medicines
Expedition Medicines, Inc.Founded in 2022 and headquartered in Cambridge, US, Expedition Medicines, Inc. specializes in creating innovative drugs targeting specific proteins.Expedition Medicines specializes in developing innovative therapeutic solutions that leverage the intersection of covalent chemistry and artificial intelligence. The company focuses on addressing unmet medical needs by creating new medicines for patients whose conditions are driven by specific proteins, which current medications cannot effectively target. Their primary offerings incorporate advanced technologies, including intelligent systems that learn from experimental data, enabling the design of novel drug candidates. The customer base includes pharmaceutical companies and biotechnology firms seeking solutions to enhance their drug development processes.Revenue generation at Expedition Medicines is structured around strategic partnerships and collaborations with other organizations in the pharmaceutical sector. The company engages in B2B transactions, partnering with established drug manufacturers and research institutions to develop and commercialize its proprietary technologies and drug candidates. Revenue is derived from contractual agreements that include milestone payments tied to drug development progress, as well as potential royalties from product sales upon successful commercialization.In October 2025, Expedition Medicines, Inc. The company plans to launch new products designed to target specific unmet medical needs and is looking to expand into new markets, particularly in Europe and North America, by 2026.
Who invested in Expedition Medicines
1 investor across 1 round
See all investors in Expedition Medicines
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Oct 22, 2025
Amount
$50M
Investors
Questions about Expedition Medicines
Who invested in Expedition Medicines?
Expedition Medicines has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Expedition Medicines raised?
Expedition Medicines has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Expedition Medicines last raise money?
Expedition Medicines's most recent round on record is a Series B, in Oct 2025.
What does Expedition Medicines do?
Expedition Medicines is a biotechnology company.
Where is Expedition Medicines headquartered?
Expedition Medicines is headquartered in Cambridge, US.
Which VCs invest in companies like Expedition Medicines?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Expedition Medicines's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Expedition Medicines? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.